MAPT and Alzheimer disease: The optical biosensors for non-Aβ-Tau biomarkers can be used in conjunction with biosensors for Aβ and Tau protein to provide a sensitive diagnostic tool for the accurate diagnosis and observation of progression or the therapeutic effects of AD.